Santiago Arroyo
Director/Board Member presso H. LUNDBECK A/S
Patrimonio netto: 971 100 $ in data 31/03/2024
Profilo
Attualmente, Santiago Arroyo ricopre la posizione di Chief Medical Officer e Senior VP-Development presso Momenta Pharmaceuticals, Inc. Il dott. Arroyo è anche nel consiglio di amministrazione di H. Lundbeck A. Il Dr. Arroyo ha precedentemente occupato la posizione di Chief Medical Officer-Biotherapeutics presso Pfizer Inc, Chief Medical Officer presso Boston Pharmaceuticals, Inc, Head-Neurosciences & Discovery Medicine presso Bristol Myers Squibb Co, Head-Global Clinical Development presso Eisai Co, Ltd., Associate Professor presso Hospital Clnic de Barcelona e Associate Professor presso The Medical College of Wisconsin, Inc. Santiago Arroyo ha ricevuto un dottorato dall'Universidad Autnoma de Madrid e un dottorato dall'Università di Barcellona.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/02/2024 | 39 000 ( 0.13% ) | 971 100 $ | 31/03/2024 |
Posizioni attive di Santiago Arroyo
| Società | Posizione | Inizio |
|---|---|---|
| H. LUNDBECK A/S | Director/Board Member | 23/03/2021 |
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31/03/2023 |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 02/05/2023 |
Precedenti posizioni note di Santiago Arroyo
| Società | Posizione | Fine |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 13/11/2022 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/10/2015 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2007 |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 01/01/2003 |
Formazione di Santiago Arroyo
| University of Barcelona | Doctorate Degree |
| Universidad Autónoma de Madrid | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 7 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |
- Borsa valori
- Insiders
- Santiago Arroyo
